Form 4 for PYXS Pyxis Oncology, Inc.
Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-17 · accession 0000078003-23-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-21 | 2023-03-17 | PYXS | PFIZER INC | 10% | P - Purchase | $2.76 | +1.81M | 5.95M | +44% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value per share | 2023-03-17 | P | A | 1,811,594 | $2.76 | 5,952,263 | D | — | — |